 HomeProductsKey IntermediatesCAS 402957-28-2 Telaprevir Powder Vx-950 HCV

Contact Supplier

Ms. Caroline

Leave a message

Contact Now

You May Like

Ranolazine Intermediate CAS 5294-61-1 powder Contact Now

Ranolazine Intermediate Guaiacol glycidyl ether Contact Now

hypoglycemic Gliclazide intermediate CAS 54528-00-6 powder Contact Now

hypoglycemic Sitagliptin Intermediate CAS 486460-00-8 Contact Now

hypoglycemic Sitagliptin Intermediate CAS 486460-21-3 powder Contact Now

Antiviral drug intermediates 102123-74-0 Navir Intermediate Contact Now

Antiviral drug intermediates Navir Intermediate Contact Now

Antiviral drug intermediates Navir Intermediate 160232-08-6 Contact Now

 

CAS 402957-28-2 Telaprevir Powder Vx-950 HCV

Name: white powder
Uploaded: 2022-12-18T13:16:44+08:00
Description: The hepatitis C virus (HCV) protease inhibitor telaprevir (VX-950, MP- 424,LY-570310) was approved by the

$80 - 120 /Kilogram

10 /Kilogram (Min. Order)

option:

10 grams per vial/bag

Payment Type:

T/T,Paypal

Incoterm:

FOB

Min. Order:

10 Kilogram

Transportation:

Land,Air,Express,Ocean

Port:

Shanghai,Shenzhen,Guangzhou

Contact Now

 Chat Now

Product Description

Product Attributes
Supply Ability & Additional Information
Packaging & Delivery

< >

Overview

Product Attributes

Model No.: Telaprevir

Brand: Rhine

Grade: Phamaceutical Grade

Place Of Origin: China

Test Method: HPLC UV COA

Specification: 10g:vial/bag

Package: Bottles, foil bags

Trademark: RHINE

Sec-HPLC: 99.5%

Cas: 402957-28-2

Molecular Formula: C36H53N7O6

MW: 679.863

Supply Ability & Additional Information

Packaging: Foil bag /bottle

Productivity: 10 kg per month

Transportation: Land,Air,Express,Ocean

Place of Origin: china

Supply Ability: 500 grams/month

Certificate: N/A

HS Code: 2934993000

Port: Shanghai,Shenzhen,Guangzhou

Payment Type: T/T,Paypal

Incoterm: FOB

Packaging & Delivery

Selling Units:: Kilogram

Package Type:: Foil bag /bottle

The hepatitis C virus (HCV) protease inhibitor telaprevir (VX-950, MP- 424,LY-570310) was approved by the U.S. FDA in May 2011 for the treatment of genotype 1 chronic HCV infection in adult patients in combination with peginterferon alfa and ribavirin (PR). Telaprevir and boceprevir (vide supra) are the first two HCV protease inhibitors to be approved for treatment of HCV infection. Telaprevir is a HCV NS3-4A protease inhibitor that exerts its antiviral effect by blocking the release of...

Product Categories : Key Intermediates

Hot Products

Email to this supplier

*Subject:
*To:

Ms. Caroline
*Email:
*Message:

Your message must be between 20-8000 characters